You May Also Like

Spoons are for soup / Milliliters (mL) are for medicine
Cite
CITE Title : Spoons are for soup / Milliliters (mL) are for medicine Corporate Authors(s) : National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Published Date : June 7, 2018 URL : https://stacks.cdc.gov/view/cdc/56558 National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. (2018). Spoons are for soup / Milliliters (mL) are for medicine. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. "Spoons are for soup / Milliliters (mL) are for medicine" (2018) National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. "Spoons are for soup / Milliliters (mL) are for medicine" , 2018 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[JPEG - 127.44 KB]
Corporate Authors:
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion.
June 7, 2018
Description:
Spoons are for Soup• Do not use household spoons to give medicines.• Spoons come in all shapes and sizes. Using a tablespoon instead of a teaspoon...
File Type:
[JPEG - 127.44 KB]
File Type:
[JPEG - 127.44 KB]

Information for clinicians on therapeutic options for COVID-19 patients
Cite
CITE Title : Information for clinicians on therapeutic options for COVID-19 patients Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : March 21, 2020 Series : Coronavirus Disease 2019 (COVID-19) URL : https://stacks.cdc.gov/view/cdc/86067 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Information for clinicians on therapeutic options for COVID-19 patients. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Information for clinicians on therapeutic options for COVID-19 patients" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Information for clinicians on therapeutic options for COVID-19 patients" , 2020 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 65.84 KB]
Corporate Authors:
National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
March 21, 2020 | Coronavirus Disease 2019 (COVID-19)
Description:
There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present clinical manage...
File Type:
[PDF - 65.84 KB]
File Type:
[PDF - 65.84 KB]